INCAGN-1949

N/A

Report date: 2024/03/26 20:00:33

Base Information

Drug NameINCAGN-1949
Drug Alias NameINCAGN 01949INCAGN-1949
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerlandUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAgenus IncLudwig Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Southern CaliforniaIncyte Biosciences International Sàrl
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasm MetastasisPancreatic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A